are compound glp-1 safe Compounded Safety: Supervised Weightloss Medications VivioMD GLP-1 Program Overview 2026:
Description
The data on GLP-1 withdrawal is sobering
Discontinuation rates at one year were similar (11% for dulaglutide vs 10% for sitagliptin), and similar to those for other diabetic treatments
How will we monitor my response to treatment, and how often will I need follow-up appointments
Orforglipron is a GLP-1 receptor agonist developed by Eli Lilly 1
Compounded GLP-1 medications obtained outside of a licensed telehealth and compounding pharmacy framework carry real safety risks
Among 331,863 matched GLP-1RAs users, the hazard ratios for pneumonia and severe sepsis were 0.60 (95% CI, 0.580.62) and 0.61 (95% CI, 0.590.63), respectively, indicating a substantial risk reduction relative to the DPP-1 is cohort (55)
